Letter to the Editor regarding “Determining prognostic factors for the treatment of primary hemifacial spasm”

Letter to the Editor regarding “Determining prognostic factors for the treatment of primary hemifacial spasm”

Saved in:

Bibliographic Details
Main Authors:	Hassan Tariq, Rai Muhammad Umar Khan
Format:	Article
Language:	English
Published:	Elsevier 2025-04-01
Series:	World Neurosurgery: X
Subjects:	Primary hemifacial spasm Microvascular decompression High-resolution imaging Intraoperative monitoring
Online Access:	http://www.sciencedirect.com/science/article/pii/S2590139725000158
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Letter to the editor regarding “Transcutaneous electrical acupoint stimulation to prevent dizziness after microvascular decompression for hemifacial spasm: A randomized controlled trial” by Yuantao Hou et al.
by: Xinyu Yang, et al.
Published: (2025-08-01)

Comparison of Surgical Outcomes in Microscopic and Fully Endoscopic Microvascular Decompression for Hemifacial Spasm
by: Kyosuke MATSUNAGA, et al.
Published: (2025-05-01)

Correlation between Delayed Relief after Microvascular Decompression and Morphology of the Lateral Spread Response in Patients with Hemifacial Spasm―Temporal versus Mandibular Branch Stimulation
by: Yuki AMANO, et al.
Published: (2025-02-01)

Monitoring of the lateral spread response combined with brainstem auditory evoked potentials in microvascular decompression for hemifacial spasm
by: Dejing Cheng, et al.
Published: (2025-06-01)

The efficacy of augmented reality technology assisted by 3D-CT reconstruction in microvascular decompression for hemifacial spasm craniotomy
by: Hailiang Shi, et al.
Published: (2025-08-01)

Application of abnormal muscle response and Z⁃L response combined monitoring during keyhole microvascular decompression of hemifacial spasm
by: YU Ju, et al.
Published: (2025-04-01)

Ritidoplastia em face espástica: relato de caso Rhytidoplasty in patient with hemifacial spasm: case report
by: Allysson Antonio Ribeiro Gomes, et al.
Published: (2011-06-01)

Twists of trouble: AICA loops as the culprit in hemifacial spasm
by: Utkarsh Pradeep, et al.
Published: (2025-08-01)

Botulinum toxin type A in the treatment of hemifacial spasm: an 11-year experience Toxina botulínica tipo A no tratamento do espasmo hemifacial: 11 anos de experiência
by: Egberto Reis Barbosa, et al.
Published: (2010-08-01)

Personality traits and their effects in patients with hemifacial spasm
by: Jeong-A Lee, et al.
Published: (2025-04-01)

Evaluating YouTube as a source of information on hemifacial spasm
by: Kimberly L. Po, et al.
Published: (2025-01-01)

Espasmo hemifacial familiar: relato de dois casos Familial hemifacial spasm: report of two cases
by: EGBERTO REIS BARBOSA, et al.
Published: (1998-03-01)

Hemifacial Spasm and Blepharospasm: Divergent Social Cognition Performance Despite Similar Neurocognitive Profiles
by: Samet Çelik
Published: (2025-08-01)

Executive functioning in patients with blepharospasm in comparison with patients with hemifacial spasm Funções executivas em pacientes com blefaroespasmo em comparação a pacientes com espasmo hemifacial
by: Fernando Machado Vilhena Dias, et al.
Published: (2009-03-01)

Hemifacial Spasm Caused by Posterior Inferior Cerebellar Artery Compression due to Vertebral Artery Aneurysm: Management with Stent-Assisted Coil Embolization
by: Nagatsuki Tomura, et al.
Published: (2025-07-01)

Efficacy of isolated periocular botulinum toxin A injections versus periocular and adjunctive lower facial injections in hemifacial spasm: a randomized, controlled, noninferiority, crossover trial
by: Akarawit Eiamsamarng, et al.
Published: (2025-12-01)

Dosage of botulinum toxin in patients undergoing treatment for hemifacial spasm: is there modification during follow-up?
by: Fátima de Menezes Dantas, et al.
Published: (2025-01-01)

Clinical Profile of Patients with Hemifacial Spasm at a Tertiary Eye Care Center in South India: A Retrospective Study
by: Manisha Kalher, et al.
Published: (2024-08-01)

Frequency of obsessive and compulsive symptoms in patients with blepharospasm and hemifacial spasm Freqüência de sintomas obsessivos e compulsivos em pacientes com blefaroespasmo e espasmo hemifacial
by: Renato P. Munhoz, et al.
Published: (2005-06-01)

Hemifacial spasm in a patient with neurofibromatosis and Arnold-Chiari malformation: a unique case association Espasmo hemifacial em paciente com neurofibromatose e malformação de Arnold-Chiari: uma associação rara
by: Andre Carvalho Felício, et al.
Published: (2007-09-01)

Clinical assessment of patients with primary and postparalytic hemifacial spasm: a retrospective study Análise clínica de pacientes com espasmo hemifacial primário e pós-paralítico: estudo retrospectivo
by: Andre Carvalho Felicio, et al.
Published: (2007-09-01)

Toxina botulínica no blefaroespasmo, no espasmo hemifacial e na distonia cervical: resultados em 33 pacientes Botulinum toxin in blepharospasm, hemifacial spasm and cervical dystonia: results in 33 patients
by: Sérgio Ap. Novis, et al.
Published: (1995-09-01)

Editorial: Advancements in surgical strategies and technologies for cranial nerve disorders
by: Jun Zhong, et al.
Published: (2025-08-01)

Espasmo hemifacial bilateral: relato de caso
by: Flavia Costa Nunes Machado, et al.
Published: (2003-03-01)

Minimal important changes of HFS-30 and HFS-7 questionnaires for patients with hemifacial spasm
by: Weerawat Saengphatrachai, et al.
Published: (2025-01-01)

Misdiagnosis of hemifacial spasm is a frequent event in the primary care setting
by: Alberto R. M. Martinez, et al.
Published: (2014-02-01)

A qualitative study of symptoms and psychological experience of patients with delayed resolution after microvascular decompression for hemifacial spasm (面肌痉挛行微血管减压术后延迟治愈患者症状体验和心理感受的质性研究)
by: JING Dan (井丹), et al.
Published: (2022-12-01)

Curative effect of botulinum toxin injection combined with MVD operation on the patients with facial spasm
by: LI Jie, et al.
Published: (2023-10-01)

A 12-Week Prospective, Double-Blind, Multicenter, Randomized Study Comparing 100 Units of Abobotulinum Toxin Type A (Dysport<sup>®</sup>) and 33.33 Units of Neubotulinum Toxin Type A (Neuronox<sup>®</sup>) for the Treatment of Hemifacial Spasm
by: Subsai Kongsaengdao, et al.
Published: (2025-04-01)

Treatment of hemifacial spasm with botulinum toxin type a: effective, long lasting and well tolerated
by: Jean Pierre Mette Batisti, et al.

Botulinum Toxin in Oculoplasty: An Overview
by: Sindhuja Murugesan, et al.
Published: (2024-09-01)

Blepharospasm with elevated anti-acetylcholine receptor antibody titer
by: Min Tang, et al.

Intraoperative Hypertensive Urgency and Hemodynamic Instability during Microvascular Decompression for Trigeminal Neuralgia
by: Pushkaran Jayapaul, et al.
Published: (2019-08-01)

Patient Burden in Dystonia Diagnosis and Botulinum Toxin Treatment: A Nationwide Survey in Turkey
by: Rezzak Yilmaz, et al.
Published: (2025-03-01)

Simultaneous maxillomandibular distraction osteogenesis in hemifacial microsomia: Report of 7 cases
by: Divya Mehrotra, et al.
Published: (2017-05-01)

Experiência com aplicação de toxina botulínica A em 115 pacientes Botulinum toxin A: experience in the treatment of 115 patients
by: Luiz Augusto F. Andrade, et al.
Published: (1997-09-01)

Understanding the Educational and Social Difficulties in Children with Hemifacial Microsomia – A Literature Review
by: Michał Pniak, et al.
Published: (2024-12-01)

Myoclonus
by: R. Rimšienė, et al.
Published: (2020-12-01)

Comparison of endoscopic and microscopic microvascular decompression for treating primary trigeminal neuralgia
by: Lei Li, et al.
Published: (2025-07-01)

CSF Tryptophan in Infantile Spasms
by: J Gordon Millichap
Published: (1992-02-01)